Navigating 4 Analyst Ratings For Evolent Health
Navigating 4 Analyst Ratings For Evolent Health
瀏覽 Evolent Health 的 4 個分析師評級
In the preceding three months, 4 analysts have released ratings for Evolent Health (NYSE:EVH), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師發佈了Evolent Health（紐約證券交易所代碼：EVH）的評級，提出了從看漲到看跌的各種觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Evolent Health, revealing an average target of $45.0, a high estimate of $52.00, and a low estimate of $38.00. A 1.47% drop is evident in the current average compared to the previous average price target of $45.67.
分析師已經爲Evolent Health設定了12個月的目標股價，顯示平均目標股價爲45.0美元，最高估計爲52.00美元，低估值爲38.00美元。與之前的平均目標價45.67美元相比，當前的平均價格下降了1.47％。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
The perception of Evolent Health by financial experts is...
通過分析師最近的行...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。